Cipla gets USFDA nod to market Lanreotide injection
==========

Cipla has received approval from the US FDA to market its Lanreotide injection, a generic medication for treating acromegaly and other conditions. The product is a therapeutic equivalent of Somatuline Depot Injection, which had sales of around USD 898 million in the US for the 12-month period ending March 2024.

#Cipla #LanreotideInjection #Usfda #Acromegaly #SomatulineDepotInjection

https://m.economictimes.com/industry/healthcare/biotech/cipla-gets-usfda-nod-to-market-lanreotide-injection/articleshow/110326237.cms